Zobrazeno 1 - 10
of 26
pro vyhledávání: '"osman köstek"'
Autor:
Nargiz Majidova, Mustafa Seyyar, Demet Işık Bayraktar, Gülhan Dinç, Elfag İsgandarov, Javid Huseynov, Alper Yaşar, Abdussamet Çelebi, Nadiye Sever, Erkam Kocaaslan, Pınar Erel, Yeşim Ağyol, Ali Kaan Güren, Rukiye Arıkan, Selver Işık, Özlem Ercelep, Güzin Demirağ, Umut Kefeli, Osman Köstek, İbrahim Vedat Bayoğlu, Murat Sarı
Publikováno v:
Biomolecules & Biomedicine (2024)
Many developing countries lack access to recommended first-line treatments for metastatic renal cell carcinoma (mRCC), such as immune checkpoint inhibitors (ICIs) or ICI-tyrosine kinase inhibitor (TKI) combinations. As a result, predictive markers ar
Externí odkaz:
https://doaj.org/article/6efa41f2967843798260bb7a256b080e
Autor:
Ali Alkan, Zeynep Gülsüm Güç, Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu, Mutlu Doğan, Tuğba Akın Telli, Özge Keskin, Çağatay Arslan, Burak Bilgin, Sema Sezgin Göksu, Hacer Demir, Elif Berna Köksoy, Osman Köstek, İsmail Ertürk, Teoman Şakalar, Arzu Yaşar, Görkem Türkkan, Büşra Kasım, Aziz Karaoğlu, Berna Çakmak Öksüzoğlu, Fulden Yumuk, Mehmet Ali Şendur, Hasan Şenol Coşkun, İrfan Çiçin, Nuri Karadurmuş, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün
Publikováno v:
Journal of Men's Health, Vol 17, Iss 4, Pp 128-134 (2021)
Introduction: The efficacy and tolerability of Enzalutamide and Abiraterone Acetate have been reported in elderly patients with metastatic castration resistant prostate cancer (mCRPC). However, there is no randomized study directly comparing antitumo
Externí odkaz:
https://doaj.org/article/b4dace8ad4e24ea2ba76c16fee1bb85f
Autor:
Selin Aktürk Esen, Yakup Ergun, Cihan Erol, Rukiye Arikan, Muhammed Muhiddin Er, Muhammed Mustafa Atci, Atakan Topçu, Gökhan Uçar, Baran Akagündüz, Musa Bariş Aykan, Miraç Özen, Naziyet Köse Baytemur, Melike Özçelik, Elif Şahin, Denizcan Güven, Serkan Menekşe, Naziye Ak, Fatih Teker, Engin Kut, Teoman Şakalar, Özkan Alan, Turgut Kaçan, Nazim Serdar Turhal, Saadettin Kiliçkap, Sema Türker, Mehmet Ali Nahit Şendur, Osman Köstek, Mustafa Karaağaç, Abdullah Sakin, Haci Mehmet Türk, Dilek Çağlayan, Şener Cihan, Yusuf Açikgöz, Doğan Uncu
Publikováno v:
Biomolecules & Biomedicine, Vol 22, Iss 5 (2022)
Fluoropyrimidine+cisplatin/oxaliplatin+trastuzumab therapy is recommended for the first-line treatment of HER2-positive metastatic gastric adenocarcinoma. However, there is no comprehensive study on which platinum-based treatment should be preferred.
Externí odkaz:
https://doaj.org/article/76c42bc31695447ca49b70652deb5b62
Autor:
Miraç Vural Keskinler, Osman Köstek, Berrin Erok, Özge Telci, Yavuz Onur Danacıoğlu, Aytekin Oğuz
Publikováno v:
Anatolian Journal of Cardiology, Vol 25, Iss 2, Pp 89-95 (2021)
Externí odkaz:
https://doaj.org/article/4de7ddc314d7473b98068b2d416d0253
Autor:
Zuhal Çalışkan, Kenan Demircioglu, Süleyman Sayar, Resul Kahraman, Ozge Caklili, Fatma Betül Özcan, Osman Köstek, Omer Faruk Baycan, Hamdi Levent Doganay, Mustafa Caliskan
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 6, Iss 3, Pp 242-247 (2019)
INTRODUCTION[|]Aim: In this study we aimed to investigate presence of subclinical atherosclerosis with measuring epicardial fat thickness (EFT) and carotid intima media thickness (c-IMT), to evaluate low level inflammation with hsCRP and to evaluate
Externí odkaz:
https://doaj.org/article/6e91b5074c41419ebc45a90f32929124
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 7, Iss 2, Pp 128-132 (2019)
Aim:Pure seminoma which is diagnosed in early stages is the most important tumor seen in young adults. Toxicity problems and patient preferences should be taken into consideration when making treatment decision. We aimed to present the data and survi
Externí odkaz:
https://doaj.org/article/f47cdbdc4c8e48b7b841d782ae0402e3
Autor:
Fatma Ceyda Korucu, Ece Senyigit, Osman Köstek, Nazım Can Demircan, Bulent Erdogan, Sernaz Uzunoglu, Irfan Cicin
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 2, Pp 80-84 (2018)
Background: In this study, it is aimed to explain the type and frequency of potential drug-drug interactions (pDDI) in patients a Medical oncology service. Methods: This study retrospective descriptive design. pDDIs were identified using the checker
Externí odkaz:
https://doaj.org/article/5a820194e0fc47629a982aed4ba5ecb9
Autor:
Nuray CAN, Ebru TAŞTEKIN, Tülin DENIZ YALTA, Necdet SÜT, Selma KORKMAZ, Ufuk USTA, Fulya ÖZ PUYAN, Ezgi GENÇ, Mert CEZIK, Busem BINBOĞA TUTUĞ, Osman KÖSTEK, Hilmi TOZKIR
Publikováno v:
Türk Patoloji Dergisi, Vol 34, Iss 2, Pp 134-142 (2018)
Objective: BRAF is the most common mutation in melanoma. The most common subtype is BRAF V600E, followed by V600K. Initially, the authors aimed to investigate whether clinicopathological features of melanoma are associated with BRAF mutations. We the
Externí odkaz:
https://doaj.org/article/c7410c8419314fd996c3fa6d2a221ba6
Autor:
Yakup Bozkaya, Nuriye Yıldırım Özdemir, Gökmen Umut Erdem, Ebru Karcı Güner, Yüksel Ürün, Nebi Serkan Demirci, Ozan Yazıcı, Osman Köstek, Nurullah Zengin
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 5-10 (2018)
Objective: In this study, our aim was to identify the main predictive factors associated with pathologic complete response (pCR) to neoadjuvantchemoradiotherapy (nCRT) in patients with locally advanced rectal cancer. Methods: The patients who had loc
Externí odkaz:
https://doaj.org/article/70647a291637400dabfdedfe0c13a05f
Autor:
Ali Gökyer, Osman Köstek, Muhammet Bekir Hacioğlu, Bülent Erdoğan, Hilmi Kodaz, Esma Türkmen, İlhan Hacıbekiroğlu, Sernaz Uzunoğlu, İrfan Çiçin
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 4, Iss 1, Pp 43-51 (2017)
INTRODUCTION[|]Multiple primary tumors are the ones that develop in the same patient at the same or different times. They are usually examined under two groups. If the second tumor is diagnosed 6 months after the first tumor is diagnosed, it is named
Externí odkaz:
https://doaj.org/article/76e64257ab034bb584e9a1c09ff30689